Innovation

Use of Dexatromethorphan; Sodium Benzoate, Phenylacetate and Phenylbuterate to Treat Autism Associated with Increased Levels of Glutamine and Glycine.

Vanderbilt University
posted on 10/31/2008

-


Innovation Details
 

This innovation is not currently available on the iBridge Network.

For more information, please contact:

lee.bridges@Vanderbilt.Edu

File Number: VU9944 


IP Protection

License Online

This innovation currently is not available for online licensing. Please contact the case manager at Vanderbilt University for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.

[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
1849

Vanderbilt University


Profile
Related Tags

Find more innovations

February 11, 2009

4,590 members 13,287 innovations 113 organizations

Browse

Alfred R Berkeley - Chairman - Pipeline Financial Group, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...